SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001047469-15-003652
Filing Date
2015-04-17
Accepted
2015-04-17 17:01:05
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4/A a2224155zs-4a.htm S-4/A 1978712
2 EX-8.1 a2224248zex-8_1.htm EX-8.1 25939
3 EX-8.2 a2224248zex-8_2.htm EX-8.2 25363
4 EX-23.1 a2224248zex-23_1.htm EX-23.1 3404
5 EX-23.2 a2224248zex-23_2.htm EX-23.2 2589
6 EX-23.3 a2224248zex-23_3.htm EX-23.3 2907
7 EX-99.1 a2224248zex-99_1.htm EX-99.1 5530
8 EX-99.2 a2224248zex-99_2.htm EX-99.2 3989
9 G1020868.JPG g1020868.jpg GRAPHIC 5753
10 G20036.JPG g20036.jpg GRAPHIC 6940
11 G199876.JPG g199876.jpg GRAPHIC 5888
  Complete submission text file 0001047469-15-003652.txt   2075403
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-202921 | Film No.: 15778855
SIC: 2834 Pharmaceutical Preparations